nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—ABCB1—ovarian cancer	0.148	1	CbGaD
Mycophenolate mofetil—SLCO1B3—Paclitaxel—ovarian cancer	0.057	0.111	CbGbCtD
Mycophenolate mofetil—UGT2B7—Epirubicin—ovarian cancer	0.0563	0.11	CbGbCtD
Mycophenolate mofetil—ABCG2—Topotecan—ovarian cancer	0.0533	0.104	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Docetaxel—ovarian cancer	0.0412	0.0805	CbGbCtD
Mycophenolate mofetil—ABCC2—Paclitaxel—ovarian cancer	0.0292	0.057	CbGbCtD
Mycophenolate mofetil—ABCC2—Carboplatin—ovarian cancer	0.0275	0.0536	CbGbCtD
Mycophenolate mofetil—ABCG2—Paclitaxel—ovarian cancer	0.0264	0.0515	CbGbCtD
Mycophenolate mofetil—ABCG2—Carboplatin—ovarian cancer	0.0248	0.0485	CbGbCtD
Mycophenolate mofetil—ABCC2—Docetaxel—ovarian cancer	0.0211	0.0412	CbGbCtD
Mycophenolate mofetil—ABCB1—Topotecan—ovarian cancer	0.0192	0.0375	CbGbCtD
Mycophenolate mofetil—ABCG2—Docetaxel—ovarian cancer	0.0191	0.0373	CbGbCtD
Mycophenolate mofetil—ABCC2—Doxorubicin—ovarian cancer	0.0157	0.0307	CbGbCtD
Mycophenolate mofetil—CYP3A5—Paclitaxel—ovarian cancer	0.0146	0.0286	CbGbCtD
Mycophenolate mofetil—ABCG2—Doxorubicin—ovarian cancer	0.0142	0.0278	CbGbCtD
Mycophenolate mofetil—CYP2C8—Paclitaxel—ovarian cancer	0.0141	0.0275	CbGbCtD
Mycophenolate mofetil—ABCB1—Vinorelbine—ovarian cancer	0.0135	0.0264	CbGbCtD
Mycophenolate mofetil—CYP3A4—Topotecan—ovarian cancer	0.0115	0.0225	CbGbCtD
Mycophenolate mofetil—CYP3A5—Docetaxel—ovarian cancer	0.0106	0.0206	CbGbCtD
Mycophenolate mofetil—ABCB1—Paclitaxel—ovarian cancer	0.00952	0.0186	CbGbCtD
Mycophenolate mofetil—CYP3A4—Vinorelbine—ovarian cancer	0.00812	0.0158	CbGbCtD
Mycophenolate mofetil—ABCB1—Docetaxel—ovarian cancer	0.00688	0.0134	CbGbCtD
Mycophenolate mofetil—CYP3A4—Paclitaxel—ovarian cancer	0.0057	0.0111	CbGbCtD
Mycophenolate mofetil—IMPDH2—oviduct—ovarian cancer	0.00566	0.0887	CbGeAlD
Mycophenolate mofetil—ABCB1—Doxorubicin—ovarian cancer	0.00513	0.01	CbGbCtD
Mycophenolate mofetil—CYP3A4—Docetaxel—ovarian cancer	0.00412	0.00805	CbGbCtD
Mycophenolate mofetil—CYP3A4—Doxorubicin—ovarian cancer	0.00307	0.006	CbGbCtD
Mycophenolate mofetil—IMPDH2—myometrium—ovarian cancer	0.00181	0.0284	CbGeAlD
Mycophenolate mofetil—IMPDH1—myometrium—ovarian cancer	0.0018	0.0282	CbGeAlD
Mycophenolate mofetil—UGT1A6—testis—ovarian cancer	0.00178	0.0279	CbGeAlD
Mycophenolate mofetil—CES2—myometrium—ovarian cancer	0.00165	0.0258	CbGeAlD
Mycophenolate mofetil—IMPDH2—uterine cervix—ovarian cancer	0.00141	0.0221	CbGeAlD
Mycophenolate mofetil—IMPDH1—uterine cervix—ovarian cancer	0.0014	0.022	CbGeAlD
Mycophenolate mofetil—IMPDH2—decidua—ovarian cancer	0.00134	0.0211	CbGeAlD
Mycophenolate mofetil—IMPDH1—decidua—ovarian cancer	0.00134	0.0209	CbGeAlD
Mycophenolate mofetil—CES2—uterine cervix—ovarian cancer	0.00128	0.0201	CbGeAlD
Mycophenolate mofetil—IMPDH2—endometrium—ovarian cancer	0.00128	0.02	CbGeAlD
Mycophenolate mofetil—IMPDH1—endometrium—ovarian cancer	0.00127	0.0199	CbGeAlD
Mycophenolate mofetil—CES2—decidua—ovarian cancer	0.00122	0.0191	CbGeAlD
Mycophenolate mofetil—IMPDH2—gonad—ovarian cancer	0.00118	0.0185	CbGeAlD
Mycophenolate mofetil—IMPDH2—uterus—ovarian cancer	0.00118	0.0184	CbGeAlD
Mycophenolate mofetil—IMPDH1—uterus—ovarian cancer	0.00117	0.0183	CbGeAlD
Mycophenolate mofetil—CES2—endometrium—ovarian cancer	0.00116	0.0182	CbGeAlD
Mycophenolate mofetil—CES2—gonad—ovarian cancer	0.00108	0.0168	CbGeAlD
Mycophenolate mofetil—CES2—uterus—ovarian cancer	0.00107	0.0167	CbGeAlD
Mycophenolate mofetil—SLCO1B3—vagina—ovarian cancer	0.00106	0.0166	CbGeAlD
Mycophenolate mofetil—IMPDH2—female reproductive system—ovarian cancer	0.00106	0.0166	CbGeAlD
Mycophenolate mofetil—IMPDH1—female reproductive system—ovarian cancer	0.00105	0.0165	CbGeAlD
Mycophenolate mofetil—IMPDH2—bone marrow—ovarian cancer	0.000997	0.0156	CbGeAlD
Mycophenolate mofetil—IMPDH1—bone marrow—ovarian cancer	0.000991	0.0155	CbGeAlD
Mycophenolate mofetil—IMPDH2—female gonad—ovarian cancer	0.000961	0.0151	CbGeAlD
Mycophenolate mofetil—CES2—female reproductive system—ovarian cancer	0.00096	0.015	CbGeAlD
Mycophenolate mofetil—UGT2B7—female reproductive system—ovarian cancer	0.00096	0.015	CbGeAlD
Mycophenolate mofetil—IMPDH2—vagina—ovarian cancer	0.000956	0.015	CbGeAlD
Mycophenolate mofetil—IMPDH1—female gonad—ovarian cancer	0.000955	0.015	CbGeAlD
Mycophenolate mofetil—IMPDH1—vagina—ovarian cancer	0.00095	0.0149	CbGeAlD
Mycophenolate mofetil—CES2—bone marrow—ovarian cancer	0.000907	0.0142	CbGeAlD
Mycophenolate mofetil—CES2—female gonad—ovarian cancer	0.000874	0.0137	CbGeAlD
Mycophenolate mofetil—CES2—vagina—ovarian cancer	0.000868	0.0136	CbGeAlD
Mycophenolate mofetil—IMPDH2—testis—ovarian cancer	0.000853	0.0134	CbGeAlD
Mycophenolate mofetil—IMPDH1—testis—ovarian cancer	0.000847	0.0133	CbGeAlD
Mycophenolate mofetil—CES1—female reproductive system—ovarian cancer	0.000791	0.0124	CbGeAlD
Mycophenolate mofetil—UGT2B7—testis—ovarian cancer	0.000775	0.0121	CbGeAlD
Mycophenolate mofetil—CES2—testis—ovarian cancer	0.000775	0.0121	CbGeAlD
Mycophenolate mofetil—CES1—female gonad—ovarian cancer	0.00072	0.0113	CbGeAlD
Mycophenolate mofetil—SLCO1B1—female reproductive system—ovarian cancer	0.000679	0.0106	CbGeAlD
Mycophenolate mofetil—ABCG2—myometrium—ovarian cancer	0.000644	0.0101	CbGeAlD
Mycophenolate mofetil—CES1—testis—ovarian cancer	0.000638	0.01	CbGeAlD
Mycophenolate mofetil—IMPDH2—lymph node—ovarian cancer	0.000618	0.00968	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymph node—ovarian cancer	0.000614	0.00962	CbGeAlD
Mycophenolate mofetil—CES2—lymph node—ovarian cancer	0.000562	0.0088	CbGeAlD
Mycophenolate mofetil—ABCC2—female reproductive system—ovarian cancer	0.000515	0.00807	CbGeAlD
Mycophenolate mofetil—ABCG2—uterine cervix—ovarian cancer	0.000501	0.00786	CbGeAlD
Mycophenolate mofetil—ABCG2—decidua—ovarian cancer	0.000478	0.00748	CbGeAlD
Mycophenolate mofetil—CYP2C8—endometrium—ovarian cancer	0.000466	0.00731	CbGeAlD
Mycophenolate mofetil—CYP3A5—uterine cervix—ovarian cancer	0.000465	0.00729	CbGeAlD
Mycophenolate mofetil—CES1—lymph node—ovarian cancer	0.000463	0.00725	CbGeAlD
Mycophenolate mofetil—ABCG2—endometrium—ovarian cancer	0.000453	0.0071	CbGeAlD
Mycophenolate mofetil—ALB—testis—ovarian cancer	0.000444	0.00695	CbGeAlD
Mycophenolate mofetil—ABCG2—uterus—ovarian cancer	0.000418	0.00655	CbGeAlD
Mycophenolate mofetil—ABCC2—testis—ovarian cancer	0.000416	0.00651	CbGeAlD
Mycophenolate mofetil—CYP2C8—female reproductive system—ovarian cancer	0.000386	0.00605	CbGeAlD
Mycophenolate mofetil—ABCG2—bone marrow—ovarian cancer	0.000355	0.00556	CbGeAlD
Mycophenolate mofetil—CYP2C8—vagina—ovarian cancer	0.000349	0.00547	CbGeAlD
Mycophenolate mofetil—ABCG2—female gonad—ovarian cancer	0.000342	0.00536	CbGeAlD
Mycophenolate mofetil—ABCG2—vagina—ovarian cancer	0.00034	0.00532	CbGeAlD
Mycophenolate mofetil—ALB—lymph node—ovarian cancer	0.000322	0.00504	CbGeAlD
Mycophenolate mofetil—ABCB1—myometrium—ovarian cancer	0.000318	0.00498	CbGeAlD
Mycophenolate mofetil—CYP3A5—female gonad—ovarian cancer	0.000317	0.00497	CbGeAlD
Mycophenolate mofetil—CYP3A5—vagina—ovarian cancer	0.000315	0.00494	CbGeAlD
Mycophenolate mofetil—CYP2C8—testis—ovarian cancer	0.000312	0.00489	CbGeAlD
Mycophenolate mofetil—ABCB1—embryo—ovarian cancer	0.000306	0.00479	CbGeAlD
Mycophenolate mofetil—ABCG2—testis—ovarian cancer	0.000303	0.00475	CbGeAlD
Mycophenolate mofetil—ABCC2—lymph node—ovarian cancer	0.000301	0.00472	CbGeAlD
Mycophenolate mofetil—CYP3A4—female reproductive system—ovarian cancer	0.000262	0.0041	CbGeAlD
Mycophenolate mofetil—ABCB1—epithelium—ovarian cancer	0.000249	0.00391	CbGeAlD
Mycophenolate mofetil—ABCB1—uterine cervix—ovarian cancer	0.000247	0.00387	CbGeAlD
Mycophenolate mofetil—ABCB1—decidua—ovarian cancer	0.000236	0.00369	CbGeAlD
Mycophenolate mofetil—ABCB1—endometrium—ovarian cancer	0.000224	0.0035	CbGeAlD
Mycophenolate mofetil—ABCG2—lymph node—ovarian cancer	0.00022	0.00344	CbGeAlD
Mycophenolate mofetil—ABCB1—gonad—ovarian cancer	0.000207	0.00325	CbGeAlD
Mycophenolate mofetil—ABCB1—uterus—ovarian cancer	0.000206	0.00323	CbGeAlD
Mycophenolate mofetil—ABCB1—female reproductive system—ovarian cancer	0.000185	0.0029	CbGeAlD
Mycophenolate mofetil—ABCB1—bone marrow—ovarian cancer	0.000175	0.00274	CbGeAlD
Mycophenolate mofetil—ABCB1—female gonad—ovarian cancer	0.000169	0.00264	CbGeAlD
Mycophenolate mofetil—ABCB1—vagina—ovarian cancer	0.000168	0.00262	CbGeAlD
Mycophenolate mofetil—ABCB1—testis—ovarian cancer	0.000149	0.00234	CbGeAlD
Mycophenolate mofetil—ABCB1—lymph node—ovarian cancer	0.000108	0.0017	CbGeAlD
Mycophenolate mofetil—Dysuria—Doxorubicin—ovarian cancer	6.21e-05	0.000299	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Doxorubicin—ovarian cancer	6.21e-05	0.000299	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Paclitaxel—ovarian cancer	6.2e-05	0.000299	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Docetaxel—ovarian cancer	6.17e-05	0.000297	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	6.16e-05	0.000297	CcSEcCtD
Mycophenolate mofetil—Sweating—Epirubicin—ovarian cancer	6.13e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—Pollakiuria—Doxorubicin—ovarian cancer	6.13e-05	0.000295	CcSEcCtD
Mycophenolate mofetil—Pain—Paclitaxel—ovarian cancer	6.1e-05	0.000294	CcSEcCtD
Mycophenolate mofetil—Constipation—Paclitaxel—ovarian cancer	6.1e-05	0.000294	CcSEcCtD
Mycophenolate mofetil—Haematuria—Epirubicin—ovarian cancer	6.1e-05	0.000294	CcSEcCtD
Mycophenolate mofetil—Confusional state—Docetaxel—ovarian cancer	6.1e-05	0.000294	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Epirubicin—ovarian cancer	6.05e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Oedema—Docetaxel—ovarian cancer	6.05e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Docetaxel—ovarian cancer	6.05e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Weight increased—Doxorubicin—ovarian cancer	6.04e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Epirubicin—ovarian cancer	6.03e-05	0.00029	CcSEcCtD
Mycophenolate mofetil—Infection—Docetaxel—ovarian cancer	6.01e-05	0.000289	CcSEcCtD
Mycophenolate mofetil—Weight decreased—Doxorubicin—ovarian cancer	6.01e-05	0.000289	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Epirubicin—ovarian cancer	6e-05	0.000289	CcSEcCtD
Mycophenolate mofetil—Hyperglycaemia—Doxorubicin—ovarian cancer	5.99e-05	0.000288	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Epirubicin—ovarian cancer	5.97e-05	0.000287	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Doxorubicin—ovarian cancer	5.95e-05	0.000287	CcSEcCtD
Mycophenolate mofetil—Shock—Docetaxel—ovarian cancer	5.95e-05	0.000286	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Docetaxel—ovarian cancer	5.93e-05	0.000285	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Docetaxel—ovarian cancer	5.92e-05	0.000285	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Doxorubicin—ovarian cancer	5.92e-05	0.000285	CcSEcCtD
Mycophenolate mofetil—Infestation—Doxorubicin—ovarian cancer	5.92e-05	0.000285	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Docetaxel—ovarian cancer	5.9e-05	0.000284	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Paclitaxel—ovarian cancer	5.88e-05	0.000283	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Docetaxel—ovarian cancer	5.88e-05	0.000283	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Epirubicin—ovarian cancer	5.85e-05	0.000281	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Paclitaxel—ovarian cancer	5.84e-05	0.000281	CcSEcCtD
Mycophenolate mofetil—Renal failure—Doxorubicin—ovarian cancer	5.82e-05	0.00028	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Doxorubicin—ovarian cancer	5.8e-05	0.000279	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Epirubicin—ovarian cancer	5.77e-05	0.000278	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Doxorubicin—ovarian cancer	5.77e-05	0.000278	CcSEcCtD
Mycophenolate mofetil—Jaundice—Doxorubicin—ovarian cancer	5.77e-05	0.000278	CcSEcCtD
Mycophenolate mofetil—Anorexia—Docetaxel—ovarian cancer	5.77e-05	0.000277	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Epirubicin—ovarian cancer	5.76e-05	0.000277	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Doxorubicin—ovarian cancer	5.75e-05	0.000277	CcSEcCtD
Mycophenolate mofetil—Urinary tract infection—Doxorubicin—ovarian cancer	5.75e-05	0.000277	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Epirubicin—ovarian cancer	5.74e-05	0.000276	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Epirubicin—ovarian cancer	5.74e-05	0.000276	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Epirubicin—ovarian cancer	5.71e-05	0.000275	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Epirubicin—ovarian cancer	5.7e-05	0.000274	CcSEcCtD
Mycophenolate mofetil—Sweating—Doxorubicin—ovarian cancer	5.68e-05	0.000273	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Epirubicin—ovarian cancer	5.67e-05	0.000273	CcSEcCtD
Mycophenolate mofetil—Urticaria—Paclitaxel—ovarian cancer	5.67e-05	0.000273	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Epirubicin—ovarian cancer	5.66e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Hypotension—Docetaxel—ovarian cancer	5.65e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Haematuria—Doxorubicin—ovarian cancer	5.64e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Epirubicin—ovarian cancer	5.64e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Paclitaxel—ovarian cancer	5.64e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Paclitaxel—ovarian cancer	5.64e-05	0.000272	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Epirubicin—ovarian cancer	5.63e-05	0.000271	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Doxorubicin—ovarian cancer	5.6e-05	0.000269	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Doxorubicin—ovarian cancer	5.58e-05	0.000269	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Doxorubicin—ovarian cancer	5.55e-05	0.000267	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Epirubicin—ovarian cancer	5.54e-05	0.000266	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Doxorubicin—ovarian cancer	5.52e-05	0.000266	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	5.51e-05	0.000265	CcSEcCtD
Mycophenolate mofetil—Insomnia—Docetaxel—ovarian cancer	5.47e-05	0.000263	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Docetaxel—ovarian cancer	5.43e-05	0.000261	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Doxorubicin—ovarian cancer	5.41e-05	0.00026	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Docetaxel—ovarian cancer	5.39e-05	0.00026	CcSEcCtD
Mycophenolate mofetil—Somnolence—Docetaxel—ovarian cancer	5.38e-05	0.000259	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Epirubicin—ovarian cancer	5.37e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Epirubicin—ovarian cancer	5.36e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Doxorubicin—ovarian cancer	5.34e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Epirubicin—ovarian cancer	5.33e-05	0.000257	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Doxorubicin—ovarian cancer	5.33e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Docetaxel—ovarian cancer	5.33e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Doxorubicin—ovarian cancer	5.31e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Doxorubicin—ovarian cancer	5.31e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Doxorubicin—ovarian cancer	5.29e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Doxorubicin—ovarian cancer	5.27e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Docetaxel—ovarian cancer	5.26e-05	0.000253	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Paclitaxel—ovarian cancer	5.26e-05	0.000253	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Doxorubicin—ovarian cancer	5.25e-05	0.000253	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Doxorubicin—ovarian cancer	5.24e-05	0.000252	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Docetaxel—ovarian cancer	5.22e-05	0.000251	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Doxorubicin—ovarian cancer	5.22e-05	0.000251	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Epirubicin—ovarian cancer	5.21e-05	0.000251	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Doxorubicin—ovarian cancer	5.21e-05	0.000251	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Epirubicin—ovarian cancer	5.18e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—Pain—Docetaxel—ovarian cancer	5.17e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—Constipation—Docetaxel—ovarian cancer	5.17e-05	0.000249	CcSEcCtD
Mycophenolate mofetil—Chills—Epirubicin—ovarian cancer	5.15e-05	0.000248	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Epirubicin—ovarian cancer	5.13e-05	0.000247	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Doxorubicin—ovarian cancer	5.12e-05	0.000246	CcSEcCtD
Mycophenolate mofetil—Asthenia—Paclitaxel—ovarian cancer	5.12e-05	0.000246	CcSEcCtD
Mycophenolate mofetil—Alopecia—Epirubicin—ovarian cancer	5.08e-05	0.000244	CcSEcCtD
Mycophenolate mofetil—Pruritus—Paclitaxel—ovarian cancer	5.05e-05	0.000243	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Epirubicin—ovarian cancer	5.03e-05	0.000242	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Epirubicin—ovarian cancer	5e-05	0.000241	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Docetaxel—ovarian cancer	4.99e-05	0.00024	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Doxorubicin—ovarian cancer	4.97e-05	0.000239	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Doxorubicin—ovarian cancer	4.95e-05	0.000238	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Docetaxel—ovarian cancer	4.95e-05	0.000238	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Doxorubicin—ovarian cancer	4.93e-05	0.000237	CcSEcCtD
Mycophenolate mofetil—Flatulence—Epirubicin—ovarian cancer	4.93e-05	0.000237	CcSEcCtD
Mycophenolate mofetil—Tension—Epirubicin—ovarian cancer	4.91e-05	0.000236	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Epirubicin—ovarian cancer	4.9e-05	0.000236	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Paclitaxel—ovarian cancer	4.88e-05	0.000235	CcSEcCtD
Mycophenolate mofetil—Nervousness—Epirubicin—ovarian cancer	4.86e-05	0.000234	CcSEcCtD
Mycophenolate mofetil—Back pain—Epirubicin—ovarian cancer	4.84e-05	0.000233	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Doxorubicin—ovarian cancer	4.82e-05	0.000232	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Epirubicin—ovarian cancer	4.81e-05	0.000231	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Doxorubicin—ovarian cancer	4.79e-05	0.00023	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Docetaxel—ovarian cancer	4.78e-05	0.00023	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Docetaxel—ovarian cancer	4.78e-05	0.00023	CcSEcCtD
Mycophenolate mofetil—Chills—Doxorubicin—ovarian cancer	4.77e-05	0.000229	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Doxorubicin—ovarian cancer	4.75e-05	0.000228	CcSEcCtD
Mycophenolate mofetil—Dizziness—Paclitaxel—ovarian cancer	4.72e-05	0.000227	CcSEcCtD
Mycophenolate mofetil—Alopecia—Doxorubicin—ovarian cancer	4.7e-05	0.000226	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Doxorubicin—ovarian cancer	4.66e-05	0.000224	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Epirubicin—ovarian cancer	4.64e-05	0.000223	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Doxorubicin—ovarian cancer	4.63e-05	0.000223	CcSEcCtD
Mycophenolate mofetil—Anaemia—Epirubicin—ovarian cancer	4.62e-05	0.000222	CcSEcCtD
Mycophenolate mofetil—Agitation—Epirubicin—ovarian cancer	4.59e-05	0.000221	CcSEcCtD
Mycophenolate mofetil—Flatulence—Doxorubicin—ovarian cancer	4.56e-05	0.000219	CcSEcCtD
Mycophenolate mofetil—Tension—Doxorubicin—ovarian cancer	4.54e-05	0.000218	CcSEcCtD
Mycophenolate mofetil—Vomiting—Paclitaxel—ovarian cancer	4.54e-05	0.000218	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Doxorubicin—ovarian cancer	4.53e-05	0.000218	CcSEcCtD
Mycophenolate mofetil—Malaise—Epirubicin—ovarian cancer	4.51e-05	0.000217	CcSEcCtD
Mycophenolate mofetil—Rash—Paclitaxel—ovarian cancer	4.5e-05	0.000217	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Paclitaxel—ovarian cancer	4.5e-05	0.000216	CcSEcCtD
Mycophenolate mofetil—Nervousness—Doxorubicin—ovarian cancer	4.49e-05	0.000216	CcSEcCtD
Mycophenolate mofetil—Vertigo—Epirubicin—ovarian cancer	4.49e-05	0.000216	CcSEcCtD
Mycophenolate mofetil—Syncope—Epirubicin—ovarian cancer	4.48e-05	0.000216	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Epirubicin—ovarian cancer	4.48e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Back pain—Doxorubicin—ovarian cancer	4.47e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Headache—Paclitaxel—ovarian cancer	4.47e-05	0.000215	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Docetaxel—ovarian cancer	4.46e-05	0.000214	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Doxorubicin—ovarian cancer	4.45e-05	0.000214	CcSEcCtD
Mycophenolate mofetil—Palpitations—Epirubicin—ovarian cancer	4.42e-05	0.000213	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Epirubicin—ovarian cancer	4.39e-05	0.000211	CcSEcCtD
Mycophenolate mofetil—Cough—Epirubicin—ovarian cancer	4.36e-05	0.00021	CcSEcCtD
Mycophenolate mofetil—Asthenia—Docetaxel—ovarian cancer	4.34e-05	0.000209	CcSEcCtD
Mycophenolate mofetil—Convulsion—Epirubicin—ovarian cancer	4.33e-05	0.000208	CcSEcCtD
Mycophenolate mofetil—Hypertension—Epirubicin—ovarian cancer	4.32e-05	0.000208	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Doxorubicin—ovarian cancer	4.29e-05	0.000207	CcSEcCtD
Mycophenolate mofetil—Pruritus—Docetaxel—ovarian cancer	4.28e-05	0.000206	CcSEcCtD
Mycophenolate mofetil—Anaemia—Doxorubicin—ovarian cancer	4.28e-05	0.000206	CcSEcCtD
Mycophenolate mofetil—Myalgia—Epirubicin—ovarian cancer	4.26e-05	0.000205	CcSEcCtD
Mycophenolate mofetil—Chest pain—Epirubicin—ovarian cancer	4.26e-05	0.000205	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Epirubicin—ovarian cancer	4.26e-05	0.000205	CcSEcCtD
Mycophenolate mofetil—Agitation—Doxorubicin—ovarian cancer	4.25e-05	0.000205	CcSEcCtD
Mycophenolate mofetil—Anxiety—Epirubicin—ovarian cancer	4.24e-05	0.000204	CcSEcCtD
Mycophenolate mofetil—Nausea—Paclitaxel—ovarian cancer	4.24e-05	0.000204	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	4.23e-05	0.000203	CcSEcCtD
Mycophenolate mofetil—Discomfort—Epirubicin—ovarian cancer	4.21e-05	0.000202	CcSEcCtD
Mycophenolate mofetil—Malaise—Doxorubicin—ovarian cancer	4.17e-05	0.000201	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Epirubicin—ovarian cancer	4.16e-05	0.0002	CcSEcCtD
Mycophenolate mofetil—Vertigo—Doxorubicin—ovarian cancer	4.16e-05	0.0002	CcSEcCtD
Mycophenolate mofetil—Syncope—Doxorubicin—ovarian cancer	4.15e-05	0.0002	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Doxorubicin—ovarian cancer	4.14e-05	0.000199	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Docetaxel—ovarian cancer	4.14e-05	0.000199	CcSEcCtD
Mycophenolate mofetil—Confusional state—Epirubicin—ovarian cancer	4.11e-05	0.000198	CcSEcCtD
Mycophenolate mofetil—Palpitations—Doxorubicin—ovarian cancer	4.09e-05	0.000197	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Epirubicin—ovarian cancer	4.08e-05	0.000196	CcSEcCtD
Mycophenolate mofetil—Oedema—Epirubicin—ovarian cancer	4.08e-05	0.000196	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Doxorubicin—ovarian cancer	4.07e-05	0.000196	CcSEcCtD
Mycophenolate mofetil—Infection—Epirubicin—ovarian cancer	4.05e-05	0.000195	CcSEcCtD
Mycophenolate mofetil—Cough—Doxorubicin—ovarian cancer	4.04e-05	0.000194	CcSEcCtD
Mycophenolate mofetil—Shock—Epirubicin—ovarian cancer	4.01e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Convulsion—Doxorubicin—ovarian cancer	4.01e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Epirubicin—ovarian cancer	4e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Dizziness—Docetaxel—ovarian cancer	4e-05	0.000193	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Epirubicin—ovarian cancer	4e-05	0.000192	CcSEcCtD
Mycophenolate mofetil—Hypertension—Doxorubicin—ovarian cancer	3.99e-05	0.000192	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Epirubicin—ovarian cancer	3.98e-05	0.000192	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Epirubicin—ovarian cancer	3.96e-05	0.000191	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Epirubicin—ovarian cancer	3.94e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Doxorubicin—ovarian cancer	3.94e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Chest pain—Doxorubicin—ovarian cancer	3.94e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Myalgia—Doxorubicin—ovarian cancer	3.94e-05	0.00019	CcSEcCtD
Mycophenolate mofetil—Anxiety—Doxorubicin—ovarian cancer	3.92e-05	0.000189	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	3.91e-05	0.000188	CcSEcCtD
Mycophenolate mofetil—Discomfort—Doxorubicin—ovarian cancer	3.89e-05	0.000187	CcSEcCtD
Mycophenolate mofetil—Anorexia—Epirubicin—ovarian cancer	3.89e-05	0.000187	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Doxorubicin—ovarian cancer	3.85e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Vomiting—Docetaxel—ovarian cancer	3.85e-05	0.000185	CcSEcCtD
Mycophenolate mofetil—Rash—Docetaxel—ovarian cancer	3.81e-05	0.000184	CcSEcCtD
Mycophenolate mofetil—Hypotension—Epirubicin—ovarian cancer	3.81e-05	0.000183	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Docetaxel—ovarian cancer	3.81e-05	0.000183	CcSEcCtD
Mycophenolate mofetil—Confusional state—Doxorubicin—ovarian cancer	3.81e-05	0.000183	CcSEcCtD
Mycophenolate mofetil—Headache—Docetaxel—ovarian cancer	3.79e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Oedema—Doxorubicin—ovarian cancer	3.78e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Doxorubicin—ovarian cancer	3.78e-05	0.000182	CcSEcCtD
Mycophenolate mofetil—Infection—Doxorubicin—ovarian cancer	3.75e-05	0.00018	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	3.72e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Shock—Doxorubicin—ovarian cancer	3.71e-05	0.000179	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Doxorubicin—ovarian cancer	3.7e-05	0.000178	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Doxorubicin—ovarian cancer	3.7e-05	0.000178	CcSEcCtD
Mycophenolate mofetil—Insomnia—Epirubicin—ovarian cancer	3.69e-05	0.000178	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Doxorubicin—ovarian cancer	3.68e-05	0.000177	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Doxorubicin—ovarian cancer	3.67e-05	0.000176	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Epirubicin—ovarian cancer	3.66e-05	0.000176	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Doxorubicin—ovarian cancer	3.65e-05	0.000176	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Epirubicin—ovarian cancer	3.64e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—Somnolence—Epirubicin—ovarian cancer	3.63e-05	0.000175	CcSEcCtD
Mycophenolate mofetil—Anorexia—Doxorubicin—ovarian cancer	3.6e-05	0.000173	CcSEcCtD
Mycophenolate mofetil—Nausea—Docetaxel—ovarian cancer	3.59e-05	0.000173	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Epirubicin—ovarian cancer	3.59e-05	0.000173	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Epirubicin—ovarian cancer	3.55e-05	0.000171	CcSEcCtD
Mycophenolate mofetil—Hypotension—Doxorubicin—ovarian cancer	3.53e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Epirubicin—ovarian cancer	3.52e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Pain—Epirubicin—ovarian cancer	3.49e-05	0.000168	CcSEcCtD
Mycophenolate mofetil—Constipation—Epirubicin—ovarian cancer	3.49e-05	0.000168	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	3.44e-05	0.000166	CcSEcCtD
Mycophenolate mofetil—Insomnia—Doxorubicin—ovarian cancer	3.41e-05	0.000164	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Doxorubicin—ovarian cancer	3.39e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Doxorubicin—ovarian cancer	3.37e-05	0.000162	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Epirubicin—ovarian cancer	3.36e-05	0.000162	CcSEcCtD
Mycophenolate mofetil—Somnolence—Doxorubicin—ovarian cancer	3.36e-05	0.000162	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Epirubicin—ovarian cancer	3.34e-05	0.000161	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Doxorubicin—ovarian cancer	3.32e-05	0.00016	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Doxorubicin—ovarian cancer	3.28e-05	0.000158	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	3.26e-05	0.000157	CcSEcCtD
Mycophenolate mofetil—Urticaria—Epirubicin—ovarian cancer	3.24e-05	0.000156	CcSEcCtD
Mycophenolate mofetil—Pain—Doxorubicin—ovarian cancer	3.23e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—Constipation—Doxorubicin—ovarian cancer	3.23e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Epirubicin—ovarian cancer	3.23e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Epirubicin—ovarian cancer	3.23e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Doxorubicin—ovarian cancer	3.11e-05	0.00015	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.09e-05	0.000149	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Epirubicin—ovarian cancer	3.01e-05	0.000145	CcSEcCtD
Mycophenolate mofetil—Urticaria—Doxorubicin—ovarian cancer	3e-05	0.000144	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Doxorubicin—ovarian cancer	2.98e-05	0.000144	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Doxorubicin—ovarian cancer	2.98e-05	0.000144	CcSEcCtD
Mycophenolate mofetil—Asthenia—Epirubicin—ovarian cancer	2.93e-05	0.000141	CcSEcCtD
Mycophenolate mofetil—Pruritus—Epirubicin—ovarian cancer	2.89e-05	0.000139	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Epirubicin—ovarian cancer	2.79e-05	0.000134	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Doxorubicin—ovarian cancer	2.78e-05	0.000134	CcSEcCtD
Mycophenolate mofetil—Asthenia—Doxorubicin—ovarian cancer	2.71e-05	0.00013	CcSEcCtD
Mycophenolate mofetil—Dizziness—Epirubicin—ovarian cancer	2.7e-05	0.00013	CcSEcCtD
Mycophenolate mofetil—Pruritus—Doxorubicin—ovarian cancer	2.67e-05	0.000129	CcSEcCtD
Mycophenolate mofetil—Vomiting—Epirubicin—ovarian cancer	2.59e-05	0.000125	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Doxorubicin—ovarian cancer	2.58e-05	0.000124	CcSEcCtD
Mycophenolate mofetil—Rash—Epirubicin—ovarian cancer	2.57e-05	0.000124	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Epirubicin—ovarian cancer	2.57e-05	0.000124	CcSEcCtD
Mycophenolate mofetil—Headache—Epirubicin—ovarian cancer	2.56e-05	0.000123	CcSEcCtD
Mycophenolate mofetil—Dizziness—Doxorubicin—ovarian cancer	2.5e-05	0.00012	CcSEcCtD
Mycophenolate mofetil—Nausea—Epirubicin—ovarian cancer	2.42e-05	0.000117	CcSEcCtD
Mycophenolate mofetil—Vomiting—Doxorubicin—ovarian cancer	2.4e-05	0.000116	CcSEcCtD
Mycophenolate mofetil—Rash—Doxorubicin—ovarian cancer	2.38e-05	0.000115	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Doxorubicin—ovarian cancer	2.38e-05	0.000114	CcSEcCtD
Mycophenolate mofetil—Headache—Doxorubicin—ovarian cancer	2.37e-05	0.000114	CcSEcCtD
Mycophenolate mofetil—Nausea—Doxorubicin—ovarian cancer	2.24e-05	0.000108	CcSEcCtD
Mycophenolate mofetil—IMPDH2—Metabolism—PIK3CA—ovarian cancer	1.71e-05	0.000251	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—YAP1—ovarian cancer	1.71e-05	0.000251	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CYP1B1—ovarian cancer	1.7e-05	0.00025	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.69e-05	0.000248	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—BRIP1—ovarian cancer	1.69e-05	0.000248	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PPP1CC—ovarian cancer	1.69e-05	0.000248	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—PTEN—ovarian cancer	1.68e-05	0.000247	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYTB—ovarian cancer	1.67e-05	0.000246	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PPP2R1A—ovarian cancer	1.67e-05	0.000246	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.67e-05	0.000245	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.66e-05	0.000245	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYTB—ovarian cancer	1.66e-05	0.000244	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.63e-05	0.00024	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PIK3CD—ovarian cancer	1.63e-05	0.000239	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.62e-05	0.000239	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.62e-05	0.000238	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.61e-05	0.000237	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SOD1—ovarian cancer	1.59e-05	0.000234	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PPP2R1A—ovarian cancer	1.58e-05	0.000233	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—YAP1—ovarian cancer	1.58e-05	0.000232	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	1.57e-05	0.000232	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.57e-05	0.000231	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—ABCB1—ovarian cancer	1.55e-05	0.000228	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—TYMS—ovarian cancer	1.52e-05	0.000224	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—PIK3CA—ovarian cancer	1.52e-05	0.000224	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—FASN—ovarian cancer	1.52e-05	0.000223	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—FASN—ovarian cancer	1.52e-05	0.000223	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PPP2R1A—ovarian cancer	1.51e-05	0.000222	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—SLC5A5—ovarian cancer	1.49e-05	0.000219	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—SLC5A5—ovarian cancer	1.49e-05	0.000219	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.48e-05	0.000218	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.46e-05	0.000215	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.46e-05	0.000215	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.46e-05	0.000215	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYTB—ovarian cancer	1.46e-05	0.000214	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.45e-05	0.000214	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PPP1CC—ovarian cancer	1.45e-05	0.000214	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—BRIP1—ovarian cancer	1.45e-05	0.000214	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	1.45e-05	0.000213	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—SLC2A1—ovarian cancer	1.44e-05	0.000212	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—SLC2A1—ovarian cancer	1.44e-05	0.000212	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.43e-05	0.00021	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PIK3CB—ovarian cancer	1.42e-05	0.000208	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.41e-05	0.000208	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.41e-05	0.000208	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ABCB1—ovarian cancer	1.4e-05	0.000206	CbGpPWpGaD
Mycophenolate mofetil—IMPDH2—Metabolism—AKT1—ovarian cancer	1.4e-05	0.000205	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—PIK3CA—ovarian cancer	1.39e-05	0.000205	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NME2—ovarian cancer	1.39e-05	0.000205	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—FASN—ovarian cancer	1.39e-05	0.000204	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.39e-05	0.000204	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP1B1—ovarian cancer	1.38e-05	0.000203	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP1B1—ovarian cancer	1.38e-05	0.000203	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—TYMS—ovarian cancer	1.38e-05	0.000202	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.37e-05	0.000202	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	1.37e-05	0.000201	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.34e-05	0.000197	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	1.32e-05	0.000194	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.29e-05	0.00019	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—FASN—ovarian cancer	1.29e-05	0.000189	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.27e-05	0.000187	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—BRIP1—ovarian cancer	1.27e-05	0.000187	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.27e-05	0.000187	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	1.27e-05	0.000186	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.27e-05	0.000186	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—AKT1—ovarian cancer	1.24e-05	0.000183	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.23e-05	0.000181	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CAV1—ovarian cancer	1.23e-05	0.000181	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PPP2R1A—ovarian cancer	1.23e-05	0.00018	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PPP2R1A—ovarian cancer	1.23e-05	0.00018	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PTEN—ovarian cancer	1.22e-05	0.00018	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.22e-05	0.00018	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.22e-05	0.000179	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.21e-05	0.000178	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—PIK3CA—ovarian cancer	1.18e-05	0.000174	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.17e-05	0.000173	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.17e-05	0.000172	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—CAV1—ovarian cancer	1.16e-05	0.000171	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.16e-05	0.000171	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.14e-05	0.000168	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ABCB1—ovarian cancer	1.14e-05	0.000167	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—AKT1—ovarian cancer	1.14e-05	0.000167	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ABCB1—ovarian cancer	1.14e-05	0.000167	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—YAP1—ovarian cancer	1.13e-05	0.000166	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	1.12e-05	0.000165	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	1.12e-05	0.000165	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—TYMS—ovarian cancer	1.12e-05	0.000164	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—TYMS—ovarian cancer	1.12e-05	0.000164	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.12e-05	0.000164	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.11e-05	0.000164	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CAV1—ovarian cancer	1.11e-05	0.000163	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.11e-05	0.000163	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.09e-05	0.00016	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.09e-05	0.00016	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.06e-05	0.000157	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CG—ovarian cancer	1.06e-05	0.000156	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.06e-05	0.000156	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ABCB1—ovarian cancer	1.04e-05	0.000153	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.04e-05	0.000153	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.03e-05	0.000151	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—TYMS—ovarian cancer	1.02e-05	0.000151	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CG—ovarian cancer	1.01e-05	0.000148	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	9.83e-06	0.000145	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—YAP1—ovarian cancer	9.8e-06	0.000144	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—YAP1—ovarian cancer	9.74e-06	0.000143	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.7e-06	0.000143	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—AKT1—ovarian cancer	9.67e-06	0.000142	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ABCB1—ovarian cancer	9.65e-06	0.000142	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.64e-06	0.000142	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	9.6e-06	0.000141	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—TYMS—ovarian cancer	9.48e-06	0.000139	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	9.45e-06	0.000139	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CD—ovarian cancer	9.31e-06	0.000137	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—FASN—ovarian cancer	9.22e-06	0.000136	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	9.14e-06	0.000134	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—SLC5A5—ovarian cancer	9.07e-06	0.000133	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CAV1—ovarian cancer	9e-06	0.000132	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CAV1—ovarian cancer	9e-06	0.000132	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYTB—ovarian cancer	8.97e-06	0.000132	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CD—ovarian cancer	8.87e-06	0.000131	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—SLC2A1—ovarian cancer	8.76e-06	0.000129	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PIK3CA—ovarian cancer	8.64e-06	0.000127	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.6e-06	0.000127	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	8.57e-06	0.000126	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—YAP1—ovarian cancer	8.54e-06	0.000126	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.53e-06	0.000125	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.48e-06	0.000125	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP1B1—ovarian cancer	8.4e-06	0.000124	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CAV1—ovarian cancer	8.25e-06	0.000121	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CG—ovarian cancer	8.2e-06	0.000121	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CG—ovarian cancer	8.2e-06	0.000121	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CB—ovarian cancer	8.12e-06	0.000119	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—FASN—ovarian cancer	7.99e-06	0.000117	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—FASN—ovarian cancer	7.94e-06	0.000117	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.88e-06	0.000116	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—SLC5A5—ovarian cancer	7.86e-06	0.000116	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PPP1CC—ovarian cancer	7.84e-06	0.000115	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—BRIP1—ovarian cancer	7.84e-06	0.000115	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	7.84e-06	0.000115	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—SLC5A5—ovarian cancer	7.81e-06	0.000115	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CB—ovarian cancer	7.73e-06	0.000114	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	7.72e-06	0.000114	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CAV1—ovarian cancer	7.64e-06	0.000112	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—SLC2A1—ovarian cancer	7.59e-06	0.000112	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—SLC2A1—ovarian cancer	7.55e-06	0.000111	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	7.52e-06	0.000111	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IL2—ovarian cancer	7.45e-06	0.00011	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	7.45e-06	0.00011	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.43e-06	0.000109	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PTEN—ovarian cancer	7.41e-06	0.000109	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.39e-06	0.000109	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP1B1—ovarian cancer	7.28e-06	0.000107	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP1B1—ovarian cancer	7.23e-06	0.000106	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CD—ovarian cancer	7.21e-06	0.000106	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CD—ovarian cancer	7.21e-06	0.000106	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—AKT1—ovarian cancer	7.06e-06	0.000104	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CG—ovarian cancer	6.96e-06	0.000102	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—FASN—ovarian cancer	6.96e-06	0.000102	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ABCB1—ovarian cancer	6.92e-06	0.000102	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SLC5A5—ovarian cancer	6.85e-06	0.000101	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—TYMS—ovarian cancer	6.79e-06	9.99e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PTEN—ovarian cancer	6.68e-06	9.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SLC2A1—ovarian cancer	6.61e-06	9.72e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	6.61e-06	9.72e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	6.45e-06	9.49e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.42e-06	9.44e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PPP2R1A—ovarian cancer	6.42e-06	9.44e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.38e-06	9.39e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP1B1—ovarian cancer	6.34e-06	9.32e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—VEGFA—ovarian cancer	6.33e-06	9.32e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CB—ovarian cancer	6.28e-06	9.24e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CB—ovarian cancer	6.28e-06	9.24e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—NRAS—ovarian cancer	6.26e-06	9.2e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CD—ovarian cancer	6.12e-06	9e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—MAPK3—ovarian cancer	5.99e-06	8.81e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ABCB1—ovarian cancer	5.99e-06	8.81e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ABCB1—ovarian cancer	5.96e-06	8.76e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—TYMS—ovarian cancer	5.88e-06	8.65e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—TYMS—ovarian cancer	5.85e-06	8.61e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	5.76e-06	8.47e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—MAPK1—ovarian cancer	5.7e-06	8.39e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PPP2R1A—ovarian cancer	5.62e-06	8.27e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CAV1—ovarian cancer	5.47e-06	8.05e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTEN—ovarian cancer	5.43e-06	7.99e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTEN—ovarian cancer	5.43e-06	7.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—KRAS—ovarian cancer	5.39e-06	7.92e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CB—ovarian cancer	5.33e-06	7.84e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—YAP1—ovarian cancer	5.26e-06	7.74e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	5.23e-06	7.69e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—TYMS—ovarian cancer	5.13e-06	7.54e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CG—ovarian cancer	4.99e-06	7.33e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTEN—ovarian cancer	4.98e-06	7.32e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CA—ovarian cancer	4.95e-06	7.28e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—ovarian cancer	4.79e-06	7.04e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CAV1—ovarian cancer	4.74e-06	6.97e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CA—ovarian cancer	4.71e-06	6.93e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CAV1—ovarian cancer	4.71e-06	6.93e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTEN—ovarian cancer	4.61e-06	6.78e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—HRAS—ovarian cancer	4.58e-06	6.73e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.53e-06	6.66e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.5e-06	6.62e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CD—ovarian cancer	4.38e-06	6.45e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CG—ovarian cancer	4.32e-06	6.35e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CG—ovarian cancer	4.29e-06	6.32e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—FASN—ovarian cancer	4.29e-06	6.31e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—AKT1—ovarian cancer	4.27e-06	6.28e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC5A5—ovarian cancer	4.22e-06	6.2e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CAV1—ovarian cancer	4.13e-06	6.08e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC2A1—ovarian cancer	4.07e-06	5.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—AKT1—ovarian cancer	4.04e-06	5.94e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.91e-06	5.74e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—AKT1—ovarian cancer	3.85e-06	5.67e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CA—ovarian cancer	3.83e-06	5.64e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CA—ovarian cancer	3.83e-06	5.64e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CB—ovarian cancer	3.82e-06	5.62e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CD—ovarian cancer	3.8e-06	5.58e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CD—ovarian cancer	3.78e-06	5.55e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CG—ovarian cancer	3.76e-06	5.53e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	3.51e-06	5.16e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.46e-06	5.09e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.31e-06	4.87e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.31e-06	4.87e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTEN—ovarian cancer	3.3e-06	4.86e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CB—ovarian cancer	3.29e-06	4.84e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CA—ovarian cancer	3.25e-06	4.78e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.22e-06	4.73e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TYMS—ovarian cancer	3.16e-06	4.65e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—AKT1—ovarian cancer	3.13e-06	4.6e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—AKT1—ovarian cancer	3.13e-06	4.6e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CB—ovarian cancer	2.88e-06	4.24e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—AKT1—ovarian cancer	2.87e-06	4.22e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTEN—ovarian cancer	2.86e-06	4.21e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTEN—ovarian cancer	2.84e-06	4.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—AKT1—ovarian cancer	2.66e-06	3.91e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CAV1—ovarian cancer	2.54e-06	3.74e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTEN—ovarian cancer	2.49e-06	3.66e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.33e-06	3.43e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.32e-06	3.41e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.04e-06	3e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.02e-06	2.97e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CA—ovarian cancer	2.01e-06	2.95e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—AKT1—ovarian cancer	1.9e-06	2.8e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.78e-06	2.61e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.76e-06	2.59e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AKT1—ovarian cancer	1.65e-06	2.42e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AKT1—ovarian cancer	1.64e-06	2.41e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTEN—ovarian cancer	1.53e-06	2.26e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AKT1—ovarian cancer	1.44e-06	2.11e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.08e-06	1.59e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AKT1—ovarian cancer	8.85e-07	1.3e-05	CbGpPWpGaD
